University Of Erlangen Nuremberg is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The University of Erlangen-Nuremberg (Friedrich-Alexander-Universität Erlangen-Nürnberg, FAU) is one of Germany's leading research universities. Located in Erlangen and Nuremberg, Bavaria, it has particular strength in medicine, life sciences, and engineering. The university hosts the FAU Medical Center and numerous neuroscience research institutes.
| Name | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| Location | Erlangen, Nuremberg, Bavaria, Germany |
| Type | Public Research University |
| Founded | 1742 |
| Students | ~40,000 |
| Website | https://www.fau.eu |
FAU was founded in 1742 by Frederick, Margrave of Brandenburg-Bayreuth, making it one of Germany's oldest universities. Over its 280-year history, FAU has evolved from a small theological seminary into one of the country's largest and most research-intensive universities. The university has a particular tradition in medicine and natural sciences.
FAU operates across multiple campuses:
Alzheimer's Disease
Parkinson's Disease
ALS / Motor Neuron Disease
Prion Diseases
| Center | Focus | Notable Work |
|---|---|---|
| Neurology Department | AD, PD, ALS, MS | Clinical trials, biomarker studies |
| Interdisciplinary Center for Bioinformatics | Bioinformatics | Genomics, proteomics, AI |
| Center for Rare Diseases | Rare neuro conditions | Gene discovery, novel therapies |
| Center for Protein Biotechnology | Protein aggregation | Drug discovery, structural biology |
| Institute of Biochemistry | Enzyme mechanisms | Drug targets, therapeutic development |
FAU researchers have made significant contributions to neurodegenerative disease research:
| Disease | Research Priority |
|---|---|
| Alzheimer's Disease | Biomarkers, clinical trials, neuroinflammation |
| Parkinson's Disease | Alpha-synuclein, LRRK2, mitochondria |
| ALS | Genetics, therapy development |
| Prion Diseases | Mechanisms, diagnostics |
| Multiple Sclerosis | Autoimmunity, remyelination |
FAU maintains extensive international partnerships:
The university offers comprehensive training:
The study of University Of Erlangen Nuremberg has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.